Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Short Interest Update

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 3,813 shares, an increase of 90.3% from the July 15th total of 2,004 shares. Based on an average daily volume of 7,078 shares, the short-interest ratio is presently 0.5 days. Currently, 0.0% of the shares of the stock are sold short.

Santen Pharmaceutical Stock Up 3.1%

Shares of SNPHY stock opened at $12.41 on Tuesday. The stock has a 50 day simple moving average of $12.52 and a 200-day simple moving average of $11.64. Santen Pharmaceutical has a 1-year low of $9.22 and a 1-year high of $13.93.

Santen Pharmaceutical Company Profile

Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.

With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.